[go: up one dir, main page]

BR9912849A - 4-amino-1-aril-piridin-2-onas de ação anticonvulsiva e processo para preparação das mesmas - Google Patents

4-amino-1-aril-piridin-2-onas de ação anticonvulsiva e processo para preparação das mesmas

Info

Publication number
BR9912849A
BR9912849A BR9912849-7A BR9912849A BR9912849A BR 9912849 A BR9912849 A BR 9912849A BR 9912849 A BR9912849 A BR 9912849A BR 9912849 A BR9912849 A BR 9912849A
Authority
BR
Brazil
Prior art keywords
amino
pyridin
aryl
ones
preparing
Prior art date
Application number
BR9912849-7A
Other languages
English (en)
Inventor
Hans Joachim Lankau
Klaus Unverferth
Thomas Arnold
Reni Bartsch
Angelika Rostock
Vladimir Granik
Sofia Grizik
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of BR9912849A publication Critical patent/BR9912849A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Patente de Invenção: <B>"4-AMINO-1-ARIL-PIRIDIN-2-ONAS DE AçãO ANTICONVULSILVA E PROCESSO PARA PREPARAçãO DAS MESMAS"<D>. A invenção refere-se a novas 4-amino-1-aril-piridin-2-onas da fórmula (1), onde n = 0, 1, 2, 3, 4, 5 e X significa hidrogênio, C~ 1~-C~ 4~-alquila, C~ 1~-C~ 4~-alcóxi, trifluormetila, trifluormetóxi ou halogênio e A amino, C~ 1~-C~ 4~-alquilamino, C~ 1~-C~ 4~-dialquilamino, morfolino, piperidino ou pirrolidino, a um processo para produção das mesmas e ao seu uso como medicamento, particularmente para tratamento de diversas formas de epilepsia.
BR9912849-7A 1998-08-07 1999-07-28 4-amino-1-aril-piridin-2-onas de ação anticonvulsiva e processo para preparação das mesmas BR9912849A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19835918A DE19835918A1 (de) 1998-08-07 1998-08-07 Neue antikonvulsiv wirkende 4-Amino-1-aryl-pyridin-2-one und Verfahren zu deren Herstellung
PCT/EP1999/005399 WO2000007988A1 (de) 1998-08-07 1999-07-28 Neue, antikonvulsiv wirkende 4-amino-1-aryl-pyridin-2-one und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
BR9912849A true BR9912849A (pt) 2001-05-08

Family

ID=7876889

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9912849-7A BR9912849A (pt) 1998-08-07 1999-07-28 4-amino-1-aril-piridin-2-onas de ação anticonvulsiva e processo para preparação das mesmas

Country Status (21)

Country Link
US (1) US6071911A (pt)
EP (1) EP1102748A1 (pt)
JP (1) JP2002522420A (pt)
KR (1) KR20010074802A (pt)
CN (1) CN1322197A (pt)
AR (1) AR021186A1 (pt)
AU (1) AU5507499A (pt)
BG (1) BG105196A (pt)
BR (1) BR9912849A (pt)
CA (1) CA2279692C (pt)
DE (1) DE19835918A1 (pt)
HU (1) HUP0103204A3 (pt)
IL (1) IL141200A0 (pt)
NO (1) NO20010575L (pt)
NZ (1) NZ509914A (pt)
PL (1) PL346013A1 (pt)
RU (1) RU2001106634A (pt)
SK (1) SK2002001A3 (pt)
TR (1) TR200100370T2 (pt)
WO (1) WO2000007988A1 (pt)
ZA (1) ZA200100999B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU229553B1 (en) 2000-06-12 2014-01-28 Eisai R & D Man Co 1,2-dihydropyridine compound, process for preparation of the same and use thereof
GB0129260D0 (en) 2001-12-06 2002-01-23 Eisai London Res Lab Ltd Pharmaceutical compositions and their uses
MY148809A (en) 2004-07-06 2013-05-31 Eisai R&D Man Co Ltd Crystals of 1,2-dihydropyridine compound and their production process
EP3893844A1 (en) 2018-12-14 2021-10-20 Eisai R&D Management Co., Ltd. Aqueous based pharmaceutical formulations of 1,2-dihydropyridine compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51118768A (en) * 1975-02-19 1976-10-18 Shigeo Senda Method for preparing 4-amino-2-pyridone derivatives
EP0110091B1 (de) * 1982-10-27 1987-01-21 Degussa Aktiengesellschaft 2-Amino-3-Acylamino-6-benzylamino-pyridin-Derivate mit anti-epileptischer Wirkung

Also Published As

Publication number Publication date
IL141200A0 (en) 2002-02-10
DE19835918A1 (de) 2000-02-10
CN1322197A (zh) 2001-11-14
PL346013A1 (en) 2002-01-14
ZA200100999B (en) 2001-12-14
NZ509914A (en) 2002-11-26
BG105196A (en) 2001-12-29
HUP0103204A2 (hu) 2002-04-29
EP1102748A1 (de) 2001-05-30
KR20010074802A (ko) 2001-08-09
CA2279692C (en) 2003-10-07
NO20010575D0 (no) 2001-02-02
AU5507499A (en) 2000-02-28
TR200100370T2 (tr) 2001-08-21
US6071911A (en) 2000-06-06
AR021186A1 (es) 2002-07-03
WO2000007988A1 (de) 2000-02-17
JP2002522420A (ja) 2002-07-23
HUP0103204A3 (en) 2002-06-28
CA2279692A1 (en) 2000-02-07
NO20010575L (no) 2001-04-04
SK2002001A3 (en) 2002-01-07
RU2001106634A (ru) 2004-02-27

Similar Documents

Publication Publication Date Title
BR9913383A (pt) Pirazol-carboxanilidas
BR9909110A (pt) Usos de esmilagenina e anzurogenina d, compoisção farmacêutica tendo propriedades intensificadoras da função cognitiva, processo para intensificar a função cognitiva, e, composição para uso do mesmo
BR9915553A (pt) Amidas de ácido antranìlico e seu emprego como medicamento
BR9913752B1 (pt) uso de um produto para proteÇço de tecidos, e, processo para tratamento de tecidos.
PT1414816E (pt) Polimorfo estavel da flibanserina, processo tecnico para a sua preparacao e sua utilizacao na preparacao de medicamentos
PT1259512E (pt) Compostos de pteridin para o tratamento da psoriase
SE0101108L (sv) En kvartär ammoniumalkylhydroxyetyl-cellulosaeter som en balsam för hår och hud
AR029707A1 (es) Utilizacion de un compuesto metalo-organico para proteger y/o reforzar las materias queratinicas, y procedimiento de tratamiento
ATE556092T1 (de) Mittel zur diagnose und therapie von ctcl
ES2190246T3 (es) Nuevos compuestos de tiazolopirimidina.
DE60231107D1 (de) Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
BR9912849A (pt) 4-amino-1-aril-piridin-2-onas de ação anticonvulsiva e processo para preparação das mesmas
ATE390130T1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
BR9808923A (pt) Composto, e, processo para fazer o mesmo
BR9915646A (pt) Intermediários, processo para a preparação de agente antibiótico macrolìdeo a partir deles
BR0013313A (pt) Derivados substituìdos de pirrolidino-2,3,4- triona-3-oxina eficazes como antagonistas de receptores de nmda
BR9812443A (pt) 1-2-3-4-5-6-hexahidro-2,6-metano-3-benzazocin-10-óis substituìdos, processos para sua preparação e seu emprego como medicamentos
BR9911559A (pt) Processo para a preparação de um composto, composto, processo para o tratamento de tumores resistentes a medicamento múltiplo, uso de um composto, e, agente e composição para tratar tumores resistentes a medicamento múltiplo.
BR0016942A (pt) Derivados substituìdos de aminometil-fenil-ciclohexano
BR0106120A (pt) Processo para produção de isolongifolanol
BR0214060A (pt) Uso de monoidroxicarbamazepina em distúrbio afetivo e de atenção e dor neuropática
BR0211223A (pt) Derivados de 4-aminociclohexanol substituìdos
BR9902051A (pt) Oxidação seletiva e a preparação de compostos aromáticos contendo grupos hidroxila.
BR9813726A (pt) Combinação de substâncias ativas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A,7A, E 8A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.